Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets
$ in Millions, $ in Millions
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Current assets:    
Cash and cash equivalents $ 144.4 $ 78.7
Restricted cash and cash equivalents 5.0 5.1
Restricted cash and cash equivalents - Asbestos 36.4 39.8
Restricted short-term investments - Asbestos 21.6 17.7
Accounts and other receivables, net 363.3 254.6
Inventories 305.1 317.4
Prepaid expenses and other current assets 26.1 31.3
Insurance receivable - Asbestos 5.0 7.5
Workers’ compensation - Asbestos 1.5 2.0
Total current assets 908.4 754.1
Property, plant and equipment, net 1,341.7 1,388.4
Operating lease right-of-use-assets 40.5 0.0
Finance lease right-of-use-assets 1.7 0.0
Goodwill 196.9 201.1
Intangible assets, net 166.7 174.4
Insurance receivable - Asbestos 38.5 43.7
Workers’ compensation - Asbestos 20.7 25.8
Deferred income taxes 989.4 1,092.9
Deferred income taxes - Asbestos 319.1 349.3
Other assets 4.7 2.9
Total assets 4,028.3 4,032.6
Current liabilities:    
Accounts payable and accrued liabilities 274.7 255.5
Accrued payroll and employee benefits 87.1 84.9
Operating lease liabilities 14.3 0.0
Finance lease liabilities 0.5 0.0
Accrued product warranties 7.0 6.8
Income taxes payable 8.9 13.4
Asbestos liability 103.9 110.5
Workers’ compensation - Asbestos 1.5 2.0
Other liabilities 12.1 9.9
Total current liabilities 510.0 483.0
Long-term debt 1,354.6 1,380.3
Deferred income taxes 81.9 80.4
Operating lease liabilities 41.4 0.0
Finance lease liabilities 1.5 0.0
Accrued product warranties 35.4 39.8
Income taxes payable 21.3 25.2
Asbestos liability 882.5 979.1
Workers’ compensation - Asbestos 20.7 25.8
Other liabilities 43.7 44.6
Total liabilities 2,993.0 3,058.2
Commitments and contingencies (Note 15)
Shareholders’ equity:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 443,144,740 shares issued and outstanding at 31 March 2020 and 442,269,905 shares issued and outstanding at 31 March 2019 230.6 230.0
Additional paid-in capital 207.3 197.6
Retained earnings 659.5 577.1
Accumulated other comprehensive loss (62.1) (30.3)
Total shareholders’ equity 1,035.3 974.4
Total liabilities and shareholders’ equity $ 4,028.3 $ 4,032.6